SCHEMBL24501481

SCHEMBL24501481

CNc1cc(C(=O)OC)c(Br)cc1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.46
ATM Q13315 2/20 0.46
POLB P06746 2/20 0.46
GAA P10253 6/20 0.45
ALDH1A1 P00352 5/20 0.45
HSD17B10 Q99714 3/20 0.45
MAPT P10636 3/20 0.45
HPGD P15428 2/20 0.45
TSHR P16473 2/20 0.45
ALOX15 P16050 1/20 0.45
GLA P06280 2/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
CFTR P13569 3/20 0.43
ABL1 P00519 1/20 0.42
PRKCI P41743 1/20 0.40
KMT2A Q03164 2/20 0.37
MAPK1 P28482 1/20 0.37
AAK1 Q2M2I8 1/20 0.36
SOS1 Q07889 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30640213 1.00 KDM4E (0.46) KDM4EATMPOLBGAAALDH1A1
SCHEMBL22835214 0.93 KDM4E (0.46) KDM4EATMPOLBGAAALDH1A1
SCHEMBL29502390 0.93 KDM4E (0.46) KDM4EATMPOLBGAAALDH1A1
SCHEMBL12190715 0.84 KDM4E (0.58) KDM4EATMPOLBGAAALDH1A1
SCHEMBL7896855 0.84 KDM4E (0.52) KDM4EATMPOLBGAAALDH1A1
SCHEMBL15133527 0.82 KDM4E (0.59) KDM4EATMPOLBGAAALDH1A1
SCHEMBL973441 0.81 KDM4E (0.49) KDM4EATMPOLBGAAALDH1A1
SCHEMBL15322951 0.81 KDM4E (0.50) KDM4EATMPOLBGAAALDH1A1
SCHEMBL972983 0.80 GAA (0.64) KDM4EATMPOLBGAAALDH1A1
SCHEMBL26122990 0.79 KDM4E (0.39) KDM4EATMPOLBGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250325552-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES INC (US) 2025-10-23 US disclosed
CN-117083271-A Substituted thiadiazolyl derivatives as DNA polymerase theta inhibitors 伊迪亚生物科学有限公司 2023-11-17 CN disclosed
EP-4255573-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS Ideaya Biosciences, Inc. (US) 2023-10-11 EP disclosed
WO-2022118210-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2022-06-09 WO disclosed
WO-2022118210-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2022-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325552-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS POLQ, POLK, POLH KDM4E 3825/4885ATM 332/4885POLB 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.